TOX3 Gene polymorphisms and breast cancer; effects and implications of the variations: review article

Breast carcinoma is the most common cause of cancer mortality among women globally. Primary and secondary prevention through avoiding known risk factors, screening for early detection of tumors with different methods as well as timely treatment, can be effective in reduction of the burden of this de...

Full description

Bibliographic Details
Main Authors: Amir Tajbakhsh, Fahimeh Afzal Javan, Mostafa Fazeli, Mahdi Rivandi, Mohammad Mahdi Kushyar, Mohammadreza Nassiri, Alireza Pasdar
Format: Article
Language:fas
Published: Tehran University of Medical Sciences 2017-08-01
Series:Tehran University Medical Journal
Subjects:
Online Access:http://tumj.tums.ac.ir/browse.php?a_code=A-10-25-5592&slc_lang=en&sid=1
_version_ 1811261046933946368
author Amir Tajbakhsh
Fahimeh Afzal Javan
Mostafa Fazeli
Mahdi Rivandi
Mohammad Mahdi Kushyar
Mohammadreza Nassiri
Alireza Pasdar
author_facet Amir Tajbakhsh
Fahimeh Afzal Javan
Mostafa Fazeli
Mahdi Rivandi
Mohammad Mahdi Kushyar
Mohammadreza Nassiri
Alireza Pasdar
author_sort Amir Tajbakhsh
collection DOAJ
description Breast carcinoma is the most common cause of cancer mortality among women globally. Primary and secondary prevention through avoiding known risk factors, screening for early detection of tumors with different methods as well as timely treatment, can be effective in reduction of the burden of this devastating disease. This can in turn prevent death and also increase survival in patients with breast cancer. Both environmental and genetic factors are involved in the pathogenesis of breast cancer. Multiple genetic factors can influence the risk and development of breast cancer. Identification of genetic variants including single nucleotide polymorphisms (SNPs), which are associated with the risk of breast cancer development, are mostly done through genetic association studies. It is demonstrated that SNP allele frequencies vary amongst different populations. It has been shown that genetic risk factors like variations in TOX high mobility group box family member 3 (TOX3), which affect the liability for neoplasm, play an important role in the development of breast cancer. Although TOX3 is expressed mainly in the brain, its expression in other tissues especially breast has also been reported. TOX3 maps to chromosome 16q12 and encodes the nuclear high-mobility group (HMG)-box. It has calcium (Ca2+)-dependent transcriptional activities and is a co-factor of cAMP response element (CRE)-binding protein (CREB) and CREB-binding protein (CBP). TOX3, activated with Ca2+, is related with activation of the promoter of some other genes including BCL2 and C3 complement and also CITED1 gene expression. It also induces activation of the c-fos promoter and therefore its expression. Genome-wide association studies (GWAS) in different populations including European, Asian and African-American have demonstrated that a SNP near its 5ʹ end and the promoter of TOX3 gene appears to be significantly associated with breast cancer susceptibility. Furthermore, breast cancer–associated SNPs lead to enhanced FOXA1 bindings and in turn, a reduction in TOX3 gene expression. This review has highlighted the importance of TOX3 function, SNPs and its association with breast cancer risk and also its potential effects on breast cancer treatment; TOX3 plays dual and somehow conflicting roles in cancer initiation and progression which remains to be further investigated.
first_indexed 2024-04-12T18:57:44Z
format Article
id doaj.art-7f521566f0fc45cc8613c89c2af35f1c
institution Directory Open Access Journal
issn 1683-1764
1735-7322
language fas
last_indexed 2024-04-12T18:57:44Z
publishDate 2017-08-01
publisher Tehran University of Medical Sciences
record_format Article
series Tehran University Medical Journal
spelling doaj.art-7f521566f0fc45cc8613c89c2af35f1c2022-12-22T03:20:17ZfasTehran University of Medical SciencesTehran University Medical Journal1683-17641735-73222017-08-01755323331TOX3 Gene polymorphisms and breast cancer; effects and implications of the variations: review articleAmir Tajbakhsh0Fahimeh Afzal Javan1Mostafa Fazeli2Mahdi Rivandi3Mohammad Mahdi Kushyar4Mohammadreza Nassiri5Alireza Pasdar6 Department of Modern Sciences & Technologies, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Student Research Committee, Department of Modern Sciences & Technologies, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Department of Modern Sciences & Technologies, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Student Research Committee, Department of Modern Sciences & Technologies, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Department of Modern Sciences & Technologies, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Student Research Committee, Department of Modern Sciences & Technologies, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Department of Modern Sciences & Technologies, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Student Research Committee, Department of Modern Sciences & Technologies, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Department of Hematology-Oncology, Emam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Iran. Biotechnology Institute, Ferdowsi University of Mashhad, Mashhad, Iran. Medical Genetics Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Department of Medical Genetics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Division of Applied Medicine, Faculty of Medicine, University of Aberdeen, Foresterhill, Aberdeen, UK. Breast carcinoma is the most common cause of cancer mortality among women globally. Primary and secondary prevention through avoiding known risk factors, screening for early detection of tumors with different methods as well as timely treatment, can be effective in reduction of the burden of this devastating disease. This can in turn prevent death and also increase survival in patients with breast cancer. Both environmental and genetic factors are involved in the pathogenesis of breast cancer. Multiple genetic factors can influence the risk and development of breast cancer. Identification of genetic variants including single nucleotide polymorphisms (SNPs), which are associated with the risk of breast cancer development, are mostly done through genetic association studies. It is demonstrated that SNP allele frequencies vary amongst different populations. It has been shown that genetic risk factors like variations in TOX high mobility group box family member 3 (TOX3), which affect the liability for neoplasm, play an important role in the development of breast cancer. Although TOX3 is expressed mainly in the brain, its expression in other tissues especially breast has also been reported. TOX3 maps to chromosome 16q12 and encodes the nuclear high-mobility group (HMG)-box. It has calcium (Ca2+)-dependent transcriptional activities and is a co-factor of cAMP response element (CRE)-binding protein (CREB) and CREB-binding protein (CBP). TOX3, activated with Ca2+, is related with activation of the promoter of some other genes including BCL2 and C3 complement and also CITED1 gene expression. It also induces activation of the c-fos promoter and therefore its expression. Genome-wide association studies (GWAS) in different populations including European, Asian and African-American have demonstrated that a SNP near its 5ʹ end and the promoter of TOX3 gene appears to be significantly associated with breast cancer susceptibility. Furthermore, breast cancer–associated SNPs lead to enhanced FOXA1 bindings and in turn, a reduction in TOX3 gene expression. This review has highlighted the importance of TOX3 function, SNPs and its association with breast cancer risk and also its potential effects on breast cancer treatment; TOX3 plays dual and somehow conflicting roles in cancer initiation and progression which remains to be further investigated.http://tumj.tums.ac.ir/browse.php?a_code=A-10-25-5592&slc_lang=en&sid=1breast neoplasms genetic predisposition to disease risk factors single nucleotide polymorphisms TOX3
spellingShingle Amir Tajbakhsh
Fahimeh Afzal Javan
Mostafa Fazeli
Mahdi Rivandi
Mohammad Mahdi Kushyar
Mohammadreza Nassiri
Alireza Pasdar
TOX3 Gene polymorphisms and breast cancer; effects and implications of the variations: review article
Tehran University Medical Journal
breast neoplasms
genetic predisposition to disease
risk factors
single nucleotide polymorphisms
TOX3
title TOX3 Gene polymorphisms and breast cancer; effects and implications of the variations: review article
title_full TOX3 Gene polymorphisms and breast cancer; effects and implications of the variations: review article
title_fullStr TOX3 Gene polymorphisms and breast cancer; effects and implications of the variations: review article
title_full_unstemmed TOX3 Gene polymorphisms and breast cancer; effects and implications of the variations: review article
title_short TOX3 Gene polymorphisms and breast cancer; effects and implications of the variations: review article
title_sort tox3 gene polymorphisms and breast cancer effects and implications of the variations review article
topic breast neoplasms
genetic predisposition to disease
risk factors
single nucleotide polymorphisms
TOX3
url http://tumj.tums.ac.ir/browse.php?a_code=A-10-25-5592&slc_lang=en&sid=1
work_keys_str_mv AT amirtajbakhsh tox3genepolymorphismsandbreastcancereffectsandimplicationsofthevariationsreviewarticle
AT fahimehafzaljavan tox3genepolymorphismsandbreastcancereffectsandimplicationsofthevariationsreviewarticle
AT mostafafazeli tox3genepolymorphismsandbreastcancereffectsandimplicationsofthevariationsreviewarticle
AT mahdirivandi tox3genepolymorphismsandbreastcancereffectsandimplicationsofthevariationsreviewarticle
AT mohammadmahdikushyar tox3genepolymorphismsandbreastcancereffectsandimplicationsofthevariationsreviewarticle
AT mohammadrezanassiri tox3genepolymorphismsandbreastcancereffectsandimplicationsofthevariationsreviewarticle
AT alirezapasdar tox3genepolymorphismsandbreastcancereffectsandimplicationsofthevariationsreviewarticle